Drug Eye Africa

Egypt recalls EIPICO Epikavit ampoule batch after laboratory non-conformity

Egypt’s Drug Authority (EDA) has ordered a Class II recall of one batch of Epikavit 10mg/ml ampoules, manufactured by the Egyptian International Pharmaceutical Industries Company (EIPICO), after EDA laboratories found the batch non-conforming to specification.

Distributors, pharmacies and health facilities must stop circulation of the batch, seize it and place it under quarantine. The recall applies only to the batch identified and not to circulation of the product generally. With an expiry of 31 January 2028, more than a year of shelf life remains.

ProductBatchExpiryManufacturer
Epikavit 10mg/ml ampoules250086531 January 2028Egyptian International Pharmaceutical Industries Company (EIPICO)

Source: Egyptian Drug Authority (EDA), Report No. (101) for 2026, November 2026: https://www.edaegypt.gov.eg/media/xjuc5jgs/2340-epikavit.pdf

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top